Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.

The message that Ainnova's CEO, Vinicio Vargas, continues to convey to audiences around the world is that this accessible, fast, and scalable solution is designed to support early intervention and ...

international study assessing the safety and efficacy of the Evolut TAVR system versus surgery in low-risk patients. These patients had a predicted 30-day mortality risk <3%, as assessed by a ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years ...

1,414 patients were randomized, with 730 receiving TAVR with either a Medtronic Evolut R, PRO, or CoreValve™ and 684 undergoing surgery. The term of the financing agreement is for three years ...

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

EW's first-quarter 2025 performance is likely to have gained from growth drivers across its businesses amid macroeconomic headwinds. IRVINE, Calif., April 16, 2025--Edwards Lifesciences (NYSE: EW ...

Recent iterations of the Evolut valve system are intended to reduce PVL, but the effects of oversizing with such valves on PVL are largely unknown. We aimed to assess, in a real-world contemporary ...